Determination of N-acetylation phenotype using caffeine as a metabolic probe and high-performance liquid chromatography with either ultraviolet detection or electrospray mass spectrometry

被引:13
作者
Baud-Camus, F
Marquet, P
Soursac, M
Davrinche, C
Farinotti, R
机构
[1] Fac Pharm Chatenay Malabry, UPRES 2706, Dept Clin Pharm, F-92296 Chatenay Malabry, France
[2] Hop Univ Dupuytren, Serv Pharmacol & Toxicol, F-87042 Limoges, France
来源
JOURNAL OF CHROMATOGRAPHY B | 2001年 / 760卷 / 01期
关键词
N-acetylation phenotype; caffeine; 1-methylxanthine; 1-methyluric acid; 5-acetylamino-6-amino-3-methyluracil;
D O I
10.1016/S0378-4347(01)00246-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid, sensitive method using liquid chromatography-electrospray mass spectrometry (LC-ES-MS) was developed and evaluated for the simultaneous quantitative determination of caffeine metabolites 1U, 1X and AAMU in human urine. This method involved a simple dilution of urine samples. The chromatographic separation was achieved on a C-18 reversed-phase column using a gradient of acetonitrile in 2 mM, pH 3.0 ammonium formate as mobile phase. After ionisation in an electrospray source, mass spectrometric detection was performed in the negative ion, selected ion monitoring mode. This method yielded acceptable accuracy and precision within the range 0.25-50 mug/ml. This analytical method was applied to investigate the N-acetylator phenotype of HIV infected patients and compared with high-performance liquid chromatography with UV detection. Its specificity was better, which appeared to be absolutely necessary to prevent errors in metabolic ratios and phenotype interpretation. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:55 / 63
页数:9
相关论文
共 16 条
[1]   DETERMINATION OF CYP1A2 AND NAT2 PHENOTYPES IN HUMAN-POPULATIONS BY ANALYSIS OF CAFFEINE URINARY METABOLITES [J].
BUTLER, MA ;
LANG, NP ;
YOUNG, JF ;
CAPORASO, NE ;
VINEIS, P ;
HAYES, RB ;
TEITEL, CH ;
MASSENGILL, JP ;
LAWSEN, MF ;
KADLUBAR, FF .
PHARMACOGENETICS, 1992, 2 (03) :116-127
[2]   ACETYLATION PHENOTYPE AND CUTANEOUS HYPERSENSITIVITY TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN HIV-INFECTED PATIENTS [J].
CARR, A ;
GROSS, AS ;
HOSKINS, JM ;
PENNY, R ;
COOPER, DA .
AIDS, 1994, 8 (03) :333-337
[3]   RAPID METHOD FOR THE ROUTINE DETERMINATION OF CAFFEINE AND ITS METABOLITES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
DOBROCKY, P ;
BENNETT, PN ;
NOTARIANNI, LJ .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 652 (01) :104-108
[4]  
EVANS DAP, 1989, PHARMACOL THERAPEUT, V42, P157
[5]   A SIMPLE TEST FOR ACETYLATOR PHENOTYPE USING CAFFEINE [J].
GRANT, DM ;
TANG, BK ;
KALOW, W .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (04) :459-464
[6]   ACETYLATOR PHENOTYPING VIA ANALYSIS OF 4 CAFFEINE METABOLITES IN HUMAN URINE BY MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY WITH MULTIWAVELENGTH DETECTION [J].
GUO, R ;
THORMANN, W .
ELECTROPHORESIS, 1993, 14 (5-6) :547-553
[7]   HUMAN N-ACETYLATION GENOTYPE DETERMINATION WITH URINARY CAFFEINE METABOLITES [J].
KILBANE, AJ ;
SILBART, LK ;
MANIS, M ;
BEITINS, IZ ;
WEBER, WW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (04) :470-477
[8]   HPLC METHOD FOR RAPID-DETERMINATION OF ACETYLATOR PHENOTYPE BY MEASURING URINARY CAFFEINE METABOLITES [J].
KLEBOVICH, I ;
ARVELA, P ;
PELKONEN, O .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1993, 11 (10) :1017-1021
[9]   Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography [J].
Krul, C ;
Hageman, G .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1998, 709 (01) :27-34
[10]   DETERMINATION OF N-ACETYLATOR PHENOTYPE USING CAFFEINE AS A PROBE COMPOUND - A COMPARISON OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND CAPILLARY ELECTROPHORESIS METHODS [J].
LLOYD, DK ;
FRIED, K ;
WAINER, IW .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 578 (02) :283-291